The syntheres of two analogues of lowdensity lipoprotein (LDL) labelled with 123i Rabbit LDL was employed or l3'I was optimized for radbpharmaceutlcal application. due to its uoefulness in pre-cliniml experimentation, although the parameters which were optlmlzed also pertain to human LDL. LDL was i
Manufacturing I-123-labelled radiopharmaceuticals. Pitfalls and solutions
✍ Scribed by Jos L.H. Eersels; Michael J. Travis; Jacobus D.M. Herscheid
- Publisher
- John Wiley and Sons
- Year
- 2005
- Tongue
- French
- Weight
- 168 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0022-2135
- DOI
- 10.1002/jlcr.922
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract The syntheses of the potent and selective serotonin reuptake complex radioligands [^123^I]‐ and [^125^I]5‐iodo‐6‐nitroquipazine (5‐iodo‐6‐nitro‐2‐piperazinylquinoline) are reported. A seven step synthetic sequence provided the BOC‐protected 5‐tributyltin‐6‐nitroquipazine precursor for r
## Synthetic routes to D-giucose derivatives labelled = 1.6 hr) = 56 hr) and with either the positron emitter 75Br or the single photon emitters 77Br 123 I (T1/2 13.3 hr) in positions 2 or 3 were investigated in order to prepare useful tracers for glucose utilization studies in brain and heart.
## Abstract Methods have been developed for radiolabelling synthetic branched polypeptides, these being based on a poly(L‐lysine) backbone with short side chains of three DL‐alanine residues and one other amino acid at the end of the branches (MW ∼45‐100 kDa). Labelling has been carried out with ga